Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with fewer treatments based on its continuous delivery of a customized formulation ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

The anatomy and physiology of the vitreous is briefly reviewed for a better understanding of the treatment options. A brief overview of vitreoretinal surgery is discussed, as well as agents that ...

Diabetic nephropathy (DN) and diabetic retinopathy (DR) are microvascular complications of diabetes. Microvascular endothelial cells are thought to be the major targets of hyperglycemic injury. In ...

Post-treatment observation revealed vision loss associated with ocular hypertension, hemorrhagic retinopathy, vitreous hemorrhage, combined traction and rhegmatogenous retinal detachment, or lens ...

According to the American Academy of Pediatrics (AAP) Committee on Child Abuse and Neglect (2001), head injuries are the chief cause of traumatic death and the leading cause of child abuse ...

Background Hydrocephalus is a significant contributor to morbidity following aneurysmal subarachnoid hemorrhage (aSAH). We aimed to investigate the association ... The primary outcome was ...